Have a personal or library account? Click to login
Open Data for Research and Strategic Monitoring in the Pharmaceutical and Biotech Industry Cover

Open Data for Research and Strategic Monitoring in the Pharmaceutical and Biotech Industry

Open Access
|Apr 2017

References

  1. Burger-Helchem T Dintrich A Guittard C Pénin J Pénin J L’innovation ouverte: définitions, pratiques et perspectives 2013 Chambre de commerce et d’industrie de Paris
  2. Chesbrough H Open innovation: The new imperative for creating and profiting from technology 2003 Harvard Business School Press 10.1108/14601060410565074
  3. Cohendet P Pénin J Patents to exclude vs include: Rethinking the management of intellectual property rights in a knowledge-based economy Technology Innovation Management Review 2011 December 12 17
  4. Deloitte Open growth. Stimulating demand for open data in the UK 2012
  5. Friese J Jung U Röhm T Spettmann R Intellectual property: an underestimated and undermanaged asset? Journal of Business Chemistry 2006 3 1 42 48
  6. Hogge B Open Data Study 2010
  7. Levin R C Klevorick K Nelson R R Winter S Appropriating the Returns from Industrial Research and Development Brooking Papers on Economic Activity 1987 3 783 820 10.2307/2534454
  8. Mansfield E Patents and Innovation: An Empirical Study Management Science 1986 32 173 180 10.1287/mnsc.32.2.173
  9. Mascarenhas B Baveja A Mamnoon J Dynamics of Core Competencies in Leading Multinational Companies California Management Review 1998 40 4 117 132 10.2307/41165967
  10. Scotchmer S Innovation and Incentives 2004 MIT Press
  11. Smith D Carrano A International large-scale sequencing meeting Human Genome News 1996 7 6 19
Language: English
Submitted on: Nov 5, 2016
|
Accepted on: Mar 15, 2017
|
Published on: Apr 4, 2017
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2017 Baldissera Giovani, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.